Authors: Tsalamanios, Emmanuel1; Yanni, Amalia E.1; Koutsari, Christina1
Source: Current Psychiatry Reviews, Volume 2, Number 2, May 2006 , pp. 215-234(20)
Publisher: Bentham Science Publishers
Abstract:
The purpose of this article is to review the current literature regarding the role of omega-3 (ω-3) fatty acids (mainly eicosapentaenoic acid and docosahexaenoic acid) in the etiology and treatment of psychiatric disorders. Omega-3 fatty acids are essential for normal structure and function of neuronal membranes. They also influence cell signaling and are precursors to the eicosanoids, which play important regulatory roles in a wide range of physiological functions. There has been considerable interest in the potential use of ω-3 fatty acids for the treatment of psychiatric disorders including depression, bipolar disorder, schizophrenia, borderline disorder, obsessive compulsive disorder and childhood developmental and psychiatric disorders. This article provides a critical review of the recent findings and discusses future directions and questions that remain unanswered.Keywords: Schizophrenia; Phospholipid Metabolism; magnetic resonance spectroscopy (MRS); phosphomonoesters; mitogen-activated protein kinase (MAPK); Bipolar Disorder; Depression
Document Type: Research article
DOI: 10.2174/157340006776875969
Affiliations: 1: Department of Internal Medicine, Endocrine Research Unit, 5-194 Joseph, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, USA.
Links for this article